BBIO icon

BridgeBio Pharma

116 hedge funds and large institutions have $3.82B invested in BridgeBio Pharma in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$25.4M
Puts
$743K
Net Calls
Net Calls Change

Top Buyers

1 +$111M
2 +$48M
3 +$22.6M
4
CS
Credit Suisse
Switzerland
+$17.5M
5
BlackRock
BlackRock
New York
+$11M

Top Sellers

1 -$77.9M
2 -$11.7M
3 -$9.73M
4
Millennium Management
Millennium Management
New York
-$6.41M
5
WAM
Weiss Asset Management
Massachusetts
-$4.68M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.13B
2
$868M
3
$219M
4
$189M
5
$183M
6
$181M
7
$154M
8
$130M
9
$104M
10
$84.5M
11
$83M
12
$57.6M
13
$50.5M
14
$33.4M
15
$30.4M
16
$26.4M
17
$25.8M
18
$23.9M
19
$23.4M
20
$19.6M
21
$17.8M
22
$13.9M
23
$12.2M
24
$10.9M
25
$8.75M